Stabilization of poliovirus by capsid-binding antiviral drugs is due to entropic effects

Journal of Molecular Biology

Volumn 296, Issue 2, 2000, Pages 335-340

  Tsang, Simon K ^a   Danthi, Pranav ^b   Chow, Marie ^b   Hogle, James M ^a,c  

^a HARVARD UNIVERSITY   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Activation energy; Antiviral; Capsid transition; Entropic stabilization; Poliovirus

Indexed keywords

ARTICLE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; DRUG BINDING; ENTROPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; TEMPERATURE; VIRION; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS PARTICLE;

EID: 0034681288     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.3483     Document Type: Article

References (25)

1. Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity
2. Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: Structure of the empty capsid assembly intermediate at 2.9 Å resolution
3. Kinetics and thermodynamics of virus binding to receptor. Studies with rhinovirus, intercellular adhesion molecule-1 (ICAM-1), and surface plasmon resonance
4. The role of conformational transitions in poliovirus pathogenesis
5. The poliovirus 135S particle is infectious
6. Cold-adapted poliovirus mutants bypass a postentry replication block
7. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus
8. Structure determination of echovirus 1
9. Cell-induced conformational change of poliovirus: Externalization of the amino terminus of VP1 is responsible for liposome binding
10. Characterization of poliovirus conformational alteration mediated by soluble cell receptors
11. Structures of poliovirus complexes with antiviral drugs: Implications for viral stability and drug design
12. Crystal structure of human rhinovirus serotype 1A (HRV1A)
13. Inhibition of uncoating of poliovirus by arildone, a new antivial drug
14. The structure of coxsackievirus B3 at 3.5 Å resolution
15. The structure of human rhinovirus 16
16. Conformation change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors
17. Molecular targets for antiviral therapy of the common cold
18. A novel basis for capsid stabilization by antiviral compounds
19. Molecular dynamics investigation of the effect of an antiviral compound on human rhinovirus
20. Influence of an antiviral compound on the temperature dependence of viral protein flexibility and packing: A molecular dynamics study
21. The poliovirus receptor: A hook, or an unzipper?
22. Picornaviridae: The viruses and their replication
23. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating
24. Implications for viral uncoating from the structure of bovine enterovirus
25. Poliovirus: New insights from an old paradigm